East Notes: Adams, JDM, Marlins, Eovaldi, Orioles
Matt Adams signed with the Nationals fairly early in the offseason knowing full well that regular at-bats were going to be difficult to come by, writes Jorge Castillo of the Washington Post. Adams prioritized playing for a contending club with a good clubhouse culture — he consulted his friend Chris Heisey about the organization before signing — over holding out for an opportunity for an everyday or near-everyday role. Castillo speaks to Adams himself, manager Dave Martinez and hitting coach Kevin Long about the slugger’s role with the club and the value he can bring off the bench. The Nationals, it should be noted, are giving Adams some looks in the outfield once again this spring and could play him in left field from time to time in 2017 — as the Cardinals and Braves both did in 2017.
More from the game’s Eastern divisions…
- Red Sox designated hitter/outfielder J.D. Martinez chats with Michael Silverman of the Boston Herald about his perceived defensive shortcomings in the outfield, explaining that his reputation as a defensive liability is frustrating. Martinez acknowledges that his glovework wasn’t at its best in 2016, when he admits to having become a bit timid around the outfield wall after breaking his elbow when crashing into the wall partway through the year. “…I got scared of running into walls because I didn’t want to get hurt again,” Martinez candidly admits. “… So balls off the wall, I just let it go and I got penalized for it.” The slugger adds that his foot injury significantly hampered his range in 2017, but he rejoined the Tigers as soon as possible as a means of getting his bat back into the lineup. Martinez, to his credit, had average to above-average ratings from both DRS and UZR from 2014-15, and he’s anxious to prove that he can still play an adequate outfield corner with better health.
- The Marlins aren’t yet certain if veteran infielder Martin Prado will be healthy enough to take the field come Opening Day, writes Andre C. Fernandez of the Miami Herald. The team’s hope is that Prado will be able to play in some Grapefruit League games by the middle of this month, but there’s still no set timeline for when he’ll get into the lineup. If Prado isn’t ready for the opneer, it could pave the way for prospect Brian Anderson, who made his MLB debut late in the 2017 season, to get a look at the hot corner and prove that he’s capable of sticking at the big league level. The Marlins won’t push Anderson into that role if they don’t feel he’s ready, though skipper Don Mattingly had plenty of praise for Anderson’s work at third, his swing and his overall work ethic.
- Nathan Eovaldi‘s contract with the Rays contains $3.5MM worth of incentives based on starting and $2.375MM worth of relief-based incentives, reports Marc Topkin of the Tampa Bay Times. The organization maintains that it is “definitely” committed to using Eovaldi as a starter, per Topkin, and that’s the right-hander’s preference as well. “I definitely want to be a starter and hold it out throughout the entire year,” Eovaldi tells Topkin. That said, it stands to reason that if Eovaldi struggles in the rotation, a move to the ‘pen is a possibility — especially given Tampa Bay’s deep stock of upper-level arms in the minors. As Topkin notes, many have long wondered what the hard-throwing Eovaldi could do in a relief role, especially when looking at his career struggles facing a lineup for the third time (.673 opponent OPS first time through the order, .692 second time, .890 third time).
- The Orioles remain open to adding a third free-agent starter after signing Andrew Cashner and bringing Chris Tillman back, writes MASNsports.com’s Roch Kubatko. They’re still checking in on everyone from Alex Cobb and Lance Lynn to former Oriole Jake Arrieta, he notes. That said, Kubatko adds that the O’s are heartened by the way their internal options have looked thus far, with Mike Wright, David Hess, Yefry Ramirez, and Rule 5 picks Nestor Cortes and Pedro Araujo all of interest to Baltimore decision-makers.
AL Notes: Orioles, Machado, Twins, Rays
It doesn’t appear Orioles general manager Dan Duquette is planning to initiate extension talks with contract-year shortstop Manny Machado. “I would never say never, but we’re going to be more focused on ’18 than beyond,” Duquette told Mark Feinsand of MLB.com. “I don’t really know what’s going to happen beyond that.” Machado, Duquette, manager Buck Showalter, center fielder Adam Jones and relievers Zach Britton and Brad Brach are all scheduled to become free agents after the season, leading Duquette to admit to Feinsand that 2018 will be the last hurrah for this particular Orioles core. If he stays the GM into 2019, Duquette hasn’t closed the door on spending in free agency next winter, but he also isn’t dismissing the idea of a rebuild. Regarding a potential teardown, Duquette offered: “There is some logic toward doing that, right? You get the premium picks in the Draft and they can become the core players for your next championship club. A lot of this is timing; it’s cyclical.”
More from the AL…
- The Twins are “unlikely” to sign any of the top remaining free agent starters – Jake Arrieta, Alex Cobb or Lance Lynn – Jim Bowden of MLB Network Radio hears (Twitter link). On paper, anyone from that group would bolster Minnesota’s rotation, which will go without injured No. 1 starter Ervin Santana to open the season, but the club hasn’t shown a willingness to meet their asking prices. Even without any of them on the books, the Twins are already on track to begin the year with a franchise-record Opening Day payroll (approximately $121.83MM).
- Right-hander Nathan Eovaldi is projected to start the year in the Rays’ rotation, but as a two-time Tommy John surgery patient, he faces long odds of making an impact, Marc Topkin of the Tampa Bay Times details. Only 31 other pitchers have made it back to the majors after undergoing a second Tommy John, which Eovaldi had as a Yankee in August 2016, while just 11 returned to start, per Topkin. That 11-man group (which Topkin lists) doesn’t offer a ton of hope, but Eovaldi is nonetheless banking on continuing as a starter. “I definitely want to be a starter and hold it out throughout the entire year,” he said. “As of now, we haven’t had any limitations, and we haven’t even talked about it.” The flamethrowing Eovaldi was a major league-caliber starter with the Dodgers, Marlins and Yankees from 2011-16, so it’s understandable that he and the Rays want to see him continue in that role. Although, his contract does include $2.375MM in relief incentives, Topkin notes.
Rays Exercise Club Option Over Nathan Eovaldi
The Rays have exercised their 2018 club option over righty Nathan Eovaldi, the team announced (h/t Marc Topkin of the Tampa Bay Times, on Twitter). He’ll earn $2MM for the coming season.
Eovaldi signed on with Tampa Bay in a contract that promised him $2MM last year just to rehab. The Rays, of course, hoped he’d show enough in working back from Tommy John and flexor tendon surgery that he could be retained for a cheap price for the season to come, and that’s just what is now going to take place.
All indications are that Eovaldi has shown signs of rounding back into form while building back arm strength this year. Indeed, there was even some suggestion he might try to return to action late in the 2017 season, though that did not come to pass.
Tampa Bay seems inclined to give Eovaldi a shot at earning a rotation spot. He has had success at times in that role previously, though never as much as his raw talent might suggest. Most recently, Eovaldi provided the Yankees with 124 2/3 innings of 4.76 ERA pitching in 2016. While homers were a big problem, he did manage career highs in fastball velocity (97 mph), swinging-strike rate (9.3%), and groundball rate (49.6%).
Rays Sign Nathan Eovaldi
FEBRUARY 14: Eovaldi can also earn up to $3.5MM in incentives in the 2018 season, Topkin adds on Twitter.
FEBRUARY 12, 8:27pm: Eovaldi will also earn $2MM in 2018 if the Rays exercise their option, Topkin reports (Twitter link).
4:04pm: Eovaldi’s pact will include a $2MM salary for 2017, a club option for 2018 and incentives, tweets ESPN’s Buster Olney.
1:30pm: The Rays are close to signing right-hander Nathan Eovaldi to a major league deal, reports Marc Topkin of the Tampa Bay Times (Twitter link). The contract will include a 2018 option, as the ACES client will miss the upcoming season while recovering from Tommy John surgery.
Eovaldi has been on the market since the Yankees released him in November, which came just over three months after his August elbow procedure. The soon-to-be 27-year-old previously underwent Tommy John surgery as an amateur, and he also had his right flexor tendon repaired during his latest operation.
Before landing on the shelf last year, the hard-throwing Eovaldi averaged a personal-high 97 mph on his fastball, registered a career-best 9.3 percent swinging-strike rate and posted a 49.6 percent ground-ball mark. Nevertheless, he struck out only seven batters per nine innings and logged a below-average 4.76 ERA over 124 2/3 innings frames. Home run troubles were the main reason Eovaldi had issues preventing runs, as he allowed HRs on 18.7 percent of fly balls.
From 2011-15, when he also spent time as a Dodger and Marlin, Eovaldi recorded a far more palatable homer-to-fly ball ratio (7.1 percent) and yielded a much better ERA (4.10) over 614 1/3 innings. Despite his velocity, Eovaldi wasn’t a strikeout artist during those five years (6.48 per nine), though he did a respectable job limiting free passes (2.92 BB/9). Going forward, Eovaldi could at least provide the Rays an intriguing relief option in 2018 if he doesn’t slot into their rotation.
Photo courtesy of USA Today Sports Images.
10 Bounceback Pitcher Candidates Still Available In Free Agency
By this point, the free agent market has thinned considerably, especially at its upper reaches. But there remain plenty of interesting players still available.
Looking through the list of unsigned players, one finds a number of recently high-performing pitchers who can likely be had on relatively (or very) modest deals. Achieving truly adequate pitching depth remains one of the game’s elusive pursuits, so there’s always opportunity for arms.
Here are some of the most intriguing names still available, featuring five starters and five relievers:
Tyson Ross: It came as a surprise when the Padres elected to non-tender Ross rather than paying him a repeat of his $9.6MM arbitration salary in his final season of eligibility, but that move leaves the 29-year-old available for other teams to take a risk. While organizations may prefer to attempt to secure multiple years of control if they roll the dice on the health of his ailing shoulder, Ross will no doubt prefer a single-season commitment. He carried a 3.07 ERA over 516 2/3 innings from 2013-15, so the upside is evident, and it’s no surprise that most of the league has some degree of interest.
Brett Anderson: Soon to turn 29, Anderson did not show well in his brief return from back surgery last year. But he turned in 180 1/3 frames of 3.69 ERA ball in 2015, and has generally been rather good when healthy, so there could still be something left in the tank. While Anderson’s extensive injury history is a major deterrent, organizations could reasonably hope that he can at least provide some useful innings during whatever stretch he is able to contribute.
Doug Fister: Entering his age-33 season after two straight duds, it’s tough to view Fister in quite the same light that one could have a year ago, when he seemed like a solid bounceback bet. That being said, he isn’t far removed from being a quality mid-rotation starter, and was at least able to turn in 32 starts in a healthy 2016 season. Unlike the other pitchers on this list, there isn’t an immediate injury to blame for the diminished value, though perhaps that also means he comes with a greater expectation of near-term contribution. If Fister can restore some of his lost groundball luster, perhaps he’d again rate as a useful rotation piece.
Nathan Eovaldi: Teams won’t be able to expect anything out of Eovaldi in 2017, as he’s expected to miss the entire year after Tommy John surgery. But he hasn’t even turned 27 and did show a personal-best 97.0 mph average fastball and 9.3% swinging-strike rate in 2016, so he remains an intriguing candidate to receive a rehab-and-return contract.
Henderson Alvarez: The long-term health outlook is perhaps even cloudier in the case of Alvarez, who couldn’t make it back to the majors in 2016 from shoulder issues. But he, too, has yet to reach his 27th birthday and he was able to provide 187 innings of 2.65 ERA ball as recently as 2014. And Alvarez did make 11 minor-league appearances last year, so there’s at least some reason to hope that he can contribute in the season to come.
Greg Holland: An obvious candidate for this list, Holland is perhaps the most fascinating relief arm still left unsigned. Once one of the game’s most dominant pitchers, the 31-year-old figures to sign with expectations of a full 2017 campaign after finishing up his TJ rehab. Like Ross, Holland has drawn wide interest and ought to be able to generate a variety of interesting and relatively lucrative opportunities.
Luke Hochevar: Now far removed from an impressive 2013 season in which he successfully transitioned from struggling starter to late-inning pen arm, Hochevar will be attempting to return from thoracic outlet surgery (after missing 2014 due to a Tommy John procedure). There’s plenty of uncertainty in the outlook for the 33-year-old, but he did put up 9.6 K/9 against just 2.2 BB/9 while working to a 3.86 ERA over 37 1/3 innings in 2016, and could be expected to return early in 2017.
Drew Storen: Still just 29, Storen was an electric reliever as recently as 2015, when he posted 11.0 K/9 and 2.6 BB/9 across 55 innings while working to a 3.44 ERA that metrics viewed as somewhat unfortunate. Though he struggled last year and showed a worrying drop in his average fastball velocity (from 94.1 mph in the season prior to 92.3 mph in 2016), Storen still put up a 10.5% swinging-strike rate that landed right at his career average. He also closed out the year by yielding just three runs in his final 17 innings while posting a 15-to-2 K/BB ratio.
Aaron Barrett: After TJ surgery derailed his sophomore 2015 season, Barret’s return was cut short with an elbow fracture. On the other hand, Storen’s former pen mate in D.C. owns a 3.47 ERA with 10.8 K/9 and 3.47 BB/9 over his 70 career MLB frames, with a 13.1% lifetime swinging-strike rate driven by his 93 to 94 mph heater and wipeout slider. Whatever team takes a shot on his future can also pick up plenty of affordable future control over Barrett, who’ll soon turn 29.
Charlie Furbush: Rotator cuff surgery is never good news for a pitcher, and returning from that procedure presents a major hurdle for the 30-year-old. But quality southpaws are always in high demand, so there’s much to be gained in the event that he can get back on track. Over his last 175 1/3 MLB frames, compiled over 2012 through 2015, Furbush provided the Mariners with a 3.23 ERA and 10.3 K/9 versus 3.0 BB/9.
Rays Discussing Several Free Agent Hitters
Newly promoted Rays general manager Erik Neander isn’t ruling out a rebuild “if the interest and market dictates,” he told Marc Topkin of the Tampa Bay Times. But, on the heels of a 68-win campaign, it seems Neander is more focused on immediately returning the Rays to relevance.
“There’s a certain belief that we have in the core of our team, that it’s not out of the question that we can compete deep into the season,” Neander said.
As Topkin previously reported, it’s unlikely the Rays will subtract their best starter, Chris Archer, from that core. But they continue to discuss left-hander Drew Smyly with other teams, and right-hander Alex Cobb is also a candidate to end up elsewhere via trade. Dealing one of those two would leave the Rays with a still-capable group that would also consist of Archer, Jake Odorizzi, Blake Snell and perhaps Matt Andriese. They’re mulling adding free agent starter Nathan Eovaldi to the mix, but he underwent Tommy John surgery in August and wouldn’t become a factor until 2018.
In order to complement what should be a respectable 2017 starting staff, the Rays are considering outside help for their bullpen and lineup, per Topkin. Specifically, the team would like to add an adept defensive outfielder and a first base/designated hitter type to its collection of position players. With the latter need in mind, Tampa Bay has discussed such left-handed free agent hitters as Pedro Alvarez, Ryan Howard, Brandon Moss, Luis Valbuena and 2016 Ray Logan Morrison. If they opt for a right-handed batter, which could make more sense given that first baseman Brad Miller and DH Nick Franklin struggle against left-handed pitchers, 2016 National League home run co-champion Chris Carter and Billy Butler are on their radar.
However, of greater intrigue than securing any of the aforementioned names is the possibility of signing Jose Bautista. While he seems like a longshot pickup for the low-payroll Rays, they could be in position to pounce on the Tampa Bay-area resident if his market doesn’t develop as hoped this offseason. Plus, because the Rays finished in the bottom 10 of the standings last season, they wouldn’t have to give up a first-round selection to sign Bautista, who rejected the Blue Jays’ qualifying offer. The Rays would instead surrender their competitive balance pick (currently No. 31 overall) in next year’s draft to ink the longtime AL East rival.
Regardless of whether they’re able to reel in Bautista, it does seem the Rays are aiming to compete next year. Last season’s subpar record notwithstanding, the club has a bevy of quality players in the fold, and free agent signing Wilson Ramos should further help matters if the catcher is able to return from a torn ACL in early 2017.
Yankees Release Nathan Eovaldi, Two Others
The Yankees have released veteran right-hander Nathan Eovaldi, per a club announcement. Also cut loose were southpaw Joe Mantiply and righty Nick Rumbelow. All three pitchers were designated for assignment ten days ago, and obviously no trades or claims were in the offing.
With the move, the 26-year-old Eovaldi will be available to the highest bidder for the first time in his career. It’s surely not how he envisioned reaching free agency — Tommy John and flexor tendon surgery made him a clear non-tender candidate in his final year of arbitration eligibility — and he won’t exactly be lining up a monster payday. But there figure to be plenty of interested teams given his intriguing pitching arsenal and young age.
It’s not yet clear what kind of deal Eovaldi will seek. Some players elect to rehab on their own and then throw before signing, as reliever Greg Holland is doing at present. Others ink multi-year deals that lock in some guaranteed money but provide upside to the signing team, as pitchers such as Kris Medlen have done in recent years.
It’s at least somewhat surprising that New York released Mantiply. He had been claimed off waivers just ten days before he was designated, seemingly suggesting that the organization hoped he’d be a candidate to be stashed upon his removal from the 40-man roster. Instead, the 25-year-old will hit the open market.
Rumbelow also just turned 25. He moved quickly through the minors and had a solid debut in the majors in 2015. But he went down early in the 2016 season and ultimately underwent a TJ procedure of his own. Rumbelow figures to draw interest from organizations intrigued at the possibility of gaining cheap control over a useful reliever in the event that his rehab is successful.
Yankees Designate Nathan Eovaldi, Joe Mantiply, Nick Rumeblow For Assignment
The Yankees announced that they’ve designated injured right-hander Nathan Eovaldi, recently claimed lefty Joe Mantiply and right-hander Nick Rumbelow for assignment. Additionally, right-hander Branden Pinder has been outrighted. Those moves, in addition to the trade of James Pazos to the Mariners, make room on the 40-man roster for the additions of infielder Miguel Andujar, lefty Dietrich Enns, shortstop Jorge Mateo and right-handers Giovanny Gallegos, Ronald Herrera and Yefrey Ramirez.
Eovaldi’s inclusion in this list will come as a surprise to many, but it’s important to recall that he underwent Tommy John/flexor tendon surgery back in August and is unlikely to be healthy enough to pitch next season. Considering the fact that he was arbitration eligible this winter and then would be a free agent after the 2017 season, there was never any chance that the Yankees were going to commit millions of dollars to him in arbitration. He’ll clear waivers and be released, freeing him up to potentially sign a backloaded two-year deal that would afford him minimal pay and a chance to rehab in 2017 plus a modest base salary for the 2018 campaign. Pinder and Rumbelow, too, suffered torn UCLs and underwent Tommy John surgery this year, though their operations were performed earlier in the year.
Mantiply, 25, logged just 2 2/3 innings and surrendered five runs on seven hits and a pair of walks in his MLB debut with the Tigers this year. His minor league work, though, was outstanding, as he pitched to a 2.73 ERA with 10.5 K/9 against 1.8 BB/9 in 59 1/3 innings between the Double-A and Triple-A levels. Though Mantiply works with limited fastball velocity, at best (he averaged 87.5 mph on his fastball in his brief September call-up), he’s posted a sub-3.00 ERA in each season of his pro career since being drafted in the 27th round by Detroit back in 2013. The Yankees claimed him off waivers earlier this month.
Mateo rates as one of the Yankees’ No. 3 prospect on the Yankees’ midseason top 30 list at MLB.com and ranked fourth among Yankees’ farmhands on Baseball America’s most recent top 10 list (which was issued after the season). Andujar (7) and Enns (25) were both on the aforementioned MLB.com list.
Nathan Eovaldi Undergoes Tommy John Surgery
AUG. 19: The Yankees announced today that Eovaldi underwent Tommy John surgery and also had his right flexor tendon repaired during the operation. Yankees head physician Dr. Christopher Ahmad performed the procedure, which figures to sideline Eovaldi for the remainder of this season and the entirety of the 2017 campaign as well.
AUG. 16: Yankees righty Nathan Eovaldi is set to undergo surgery to repair both a torn flexor tendon and a partially torn ulnar collateral ligament in his elbow, ESPN New York’s Wallace Mathews was among those to report (Twitter links). The pair of procedures will prevent him from pitching in 2017.
The news could well spell the end of Eovaldi’s tenure with the Yankees. He is entering his final season of arbitration eligibility, and will surely command at least some kind of a raise on his current $5.6MM salary. Unless New York looks to work out some kind of multi-year arrangement, then, Eovaldi will likely be non-tendered this fall.
Presuming that Eovaldi is fitted with a new UCL as part of the work being done, this will be his second trip through the Tommy John process — with his first coming during his amateur days. That prior procedure increased the 26-year-old’s likelihood of requiring Tommy John surgery this year, as MLBTR contributor Bradley Woodrum explained in his recent statistical study. That — along with the concurrent flexor tendon injury — also likely means that he’ll face a longer and more difficult road back than a typical, first-time TJ patient.
This crushing injury brings a disappointing end to what had already been a frustrating campaign. Eovaldi averaged 97.0 mph with his fastball and ran up a 9.3% swinging strike rate — both personal highs — but managed only a 4.76 ERA over his 124 2/3 innings. Despite a 49.6% groundball rate, Eovaldi surrendered a lot of hard contact and coughed up 1.66 home runs per nine innings.
Long an intriguing talent, Eovaldi has not yet managed to fully harness his gifts at the major league level. He has never previously had home run issues — quite the contrary, in fact — but still underperformed his fairly promising peripherals in each of the last two years, when ERA estimators valued him as a sub-4.00 pitcher.
Eovaldi carries a 4.21 ERA over his 739 lifetime innings, though a 3.85 career FIP also leads to a solid accumulation of 9.3 fWAR. That kind of output makes him a useful back-of-the-rotation arm with some room to grow, but it’s fair to wonder whether the bullpen lies in his future. After all, Eovaldi’s big-time fastball would likely play up in a relief role, where he could also limit his often-inconsistent secondary offerings and reduce the toll on his arm. And over his career, Eovaldi has limited batters to a sub-.700 OPS the first and second times through the order, with that number shooting up to .887 for hitters seeing him the third time in a day.
Yankees Place Nathan Eovaldi On DL, Recall Luis Severino
The Yankees announced today that right-hander Nathan Eovaldi, who left his most recent start after one inning due to an elbow issue, has been placed on the 15-day disabled list with a “right elbow tendon injury.” Fellow righty Luis Severino has been recalled from Triple-A Scranton-Wilkes/Barre to take his spot on the roster.
[Related: Updated New York Yankees Depth Chart]
While the DL placement obviously isn’t an ideal outcome for team or player, the fact that the announcement indicates a tendon injury is a silver lining. There was some concern about the possibility of a ligament issue at the initial time of the injury, but there’s no word from the team of any damage to Eovaldi’s UCL (thus, seemingly removing Tommy John surgery as a possibility). Severino will join Masahiro Tanaka, CC Sabathia and Michael Pineda in the New York rotation, although right-hander Chad Green has been an oft-utilized option for the Yanks this year, making eight appearances (four starts) at the big league level. Long reliever Anthony Swarzak could be another option, though he hasn’t tossed more than 2 2/3 innings in any given appearance in 2016.
Severino, 22, had been optioned out just days prior to his recall but was eligible to be brought back more quickly than the 10-day minimum due to the fact that he’s replacing an injured player. The former top prospect hasn’t followed up on his brilliant rookie campaign (2.89 ERA, 8.1 K/9, 3.2 BB/9 in 11 starts) this year, however, as he’s limped to a 6.42 earned run average in 47 2/3 innings at the Major League level. However, with Eovaldi on the shelf and right-hander Ivan Nova having been traded to the Pirates just prior to the non-waiver deadline, Severino could have an opportunity to finish the season on a strong note.